Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
31.1 USD -2.05% Intraday chart for Neurogene Inc. +2.57% +60.47%
18/06 Neurogene Doses First Patient in High-Dose Group of Rett Syndrome Trial MT
18/06 Neurogene Inc. Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett Syndrome CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. News Neurogene Inc.
  5. MarketScreener Strategies